|10.19||-0.37 / -3.50%|
Data as of 3:59pm ET
|10.30||+0.1139 / +1.12%|
The 2 analysts offering 12-month price forecasts for Vanda Pharmaceuticals Inc have a median target of 27.50, with a high estimate of 30.00 and a low estimate of 25.00. The median estimate represents a +169.87% increase from the last price of 10.19.
The current consensus among 2 polled investment analysts is to Buy stock in Vanda Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.